NCT06730334Recruiting
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
A Single Centre Prospective Cohort Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Source: ClinicalTrials.gov · Last updated 20 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 6 Dec 2024
- Start date
- 1 Sept 2023
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Nanjing Medical University
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT06730334
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Sept 2023 to the primary completion date, 1 Sept 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant disease with acute or chronic infectious diseases
Other illness
- History of other arthritis within the last 12 months
Other
- Pregnancy or laction
- Poorly tolerated with venipuncture required for blood sampling during the study
Who the study is looking for
- PsA patients as defined by CASPAR criteria
- Patients must be able to comply with the visit schedule, treatment plan, laboratory tests and other study procedures
- Patients must be given informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jiangsu Province Hospital Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
| Department of Rheumatology and Immunology, Jiangsu Province Hospital Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
Related publications
- Ultrasound dactylitis predicts bone erosion in early psoriatic arthritis: A longitudinal cohort study.Eur J Radiol · 2026 · PMID 41621380
This page is information, not medical advice. Discuss any trial with your doctor.